Flexible dosing with Darbepoetin alfa for the treatment of chemotherapy-induced anemia
Therapeutics and Clinical Risk Management · 2006
DOI: 10.2147/tcrm.2006.2.2.175 ↗Kurz gefasst
Fachartikel in der Zeitschrift Therapeutics and Clinical Risk Management, 2006. Verfasst von Isabelle Wauters und 2 weiteren Autor:innen. Beteiligte Einrichtung: Respiratory Oncology Unit (Pulmonology) and Leuven Lung Cancer Group University Hospital Gasthuisberg, Catholic University, Leuven, Belgium. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Respiratory Oncology Unit (Pulmonology) and Leuven Lung Cancer Group University Hospital Gasthuisberg, Catholic University, Leuven, Belgium.
Zitieren
APA
Wauters, I., Pat, K., & Vansteenkiste, J. (2006). Flexible dosing with Darbepoetin alfa for the treatment of chemotherapy-induced anemia. Therapeutics and Clinical Risk Management. https://doi.org/10.2147/tcrm.2006.2.2.175
Vancouver
Wauters I, Pat K, Vansteenkiste J. Flexible dosing with Darbepoetin alfa for the treatment of chemotherapy-induced anemia. Therapeutics and Clinical Risk Management. 2006. doi:10.2147/tcrm.2006.2.2.175
BibTeX
@article{Wauters2006,
author = {Wauters, Isabelle and Pat, Karin and Vansteenkiste, Johan},
title = {Flexible dosing with Darbepoetin alfa for the treatment of chemotherapy-induced anemia},
journal = {Therapeutics and Clinical Risk Management},
year = {2006},
doi = {10.2147/tcrm.2006.2.2.175}
}
EUVIMED